In a major development, India will be manufacturing the single-dose COVID-19 vaccine developed by United States (US) based pharmaceutical giant Johnson & Johnson (J&J) as part of the first Quad vaccine initiative, reports Times of India.
The entire project will be financed by Japan and the US, while Australia will chip in its logistics capabilities to ship the Made in India vaccines to Southeast Asia and Pacific nations. India's role in the entire initiative will project and reinforce the country's credentials as a trustworthy and reliable manufacturer and supplier of quality vaccines.
The move will also bolster India's standing as the "pharmacy of the world".
The development comes as the four nations in the Quad grouping are set to hold their maiden leaders' summit today (12 March), wherein Prime Ministers (PMs) Narendra Modi, Yoshihide Suga, Scott Morrison and President Joe Biden will be coming together to pursue and advance mutual interests.
The maiden Quad leaders' summit also gains significance as it would mark one of the earliest multi-lateral summits by the new administration in the US led by President Biden. Before this, President Biden has only held a virtual meeting of the G-7 block of nations.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.